Medication info

Diasis Bisan (Sodium Bicarbonate)

Prescription medication
Ingredient · strength
Sodium Bicarbonate›1g / 1g
Manufacturer / importer
Korea Hutex Pharmaceutical Co., Ltd.
Appearance
White crystalline powder in a white polyethylene bag
Packaging
16.8 kilograms/box [(8.4 kilograms/PE bag x 2)]
Approval status
Active

MFDS item code 202500433 · Approved 2025.02.27 · Insurance code 649106092

Summary

Main use
Hemodialysis for renal failure and detoxification from toxic substances
Who uses it
Adults
Adult dosage
1. When using the specified acetate-containing dialysate (Solution A), this product can prepare approximately 180L of bicarbonate-type hemodialysis dialysate containing 38mEq/L of HCO3-. 2. Use as dialysate for hemodialysis using a bicarbonate-type dialysate delivery system at a dilution ratio of 1 part acetate-containing dialysate (Solution A) to 34 parts (this medication + purified water). 3. The mixing ratio for preparing dialysate for one treatment (based on 6 hours) per patient is as follows. Solution A : (sodium bicarbonate + purified water) = 5L : (650g + 170L) 4. For standard bicarbonate-type hemodialysis, adjust the electrolyte concentrations as follows using a dialysate delivery system. Na+ : 140mEq/L HCO3- : 34mEq/L

Ingredients

Manufacturer
Korea Hutex Pharmaceutical Co., Ltd.

Efficacy & effects

Hemodialysis for renal failure and detoxification from toxic substances

View approved original text

This medication is used during bicarbonate dialysis for patients with acute and chronic renal failure, and also for preparing dialysis solutions necessary for detoxification of toxic substances.

Dosage and Administration

Adult dosage

1. When using the specified acetate-containing dialysate (Solution A), this product can prepare approximately 180L of bicarbonate-type hemodialysis dialysate containing 38mEq/L of HCO3-. 2. Use as dialysate for hemodialysis using a bicarbonate-type dialysate delivery system at a dilution ratio of 1 part acetate-containing dialysate (Solution A) to 34 parts (this medication + purified water). 3. The mixing ratio for preparing dialysate for one treatment (based on 6 hours) per patient is as follows. Solution A : (sodium bicarbonate + purified water) = 5L : (650g + 170L) 4. For standard bicarbonate-type hemodialysis, adjust the electrolyte concentrations as follows using a dialysate delivery system. Na+ : 140mEq/L HCO3- : 34mEq/L

Precautions

This drug should not be used in patients with very low blood pressure or rapid pulse. Patients with pulmonary edema or significant ECG changes should also not receive this drug. Use in patients with elevated serum potassium levels or coagulation issues may also be dangerous. Caution is advised in patients with severely impaired liver function or metabolic disturbances due to diabetes. Particularly, patients on digitalis preparations should be careful of intoxication risks due to changes in potassium levels. In patients with high serum calcium and phosphorus levels before dialysis, this drug may cause ectopic calcification, so caution should be exercised. Patients with insufficient calorie intake or dietary restrictions due to diabetes should be monitored for hypoglycemia risk. Hypoglycemia may occur with this drug, so appropriate measures such as glucose injection or sugar supplementation should be taken if symptoms of low blood sugar arise. Serum calcium levels may increase, requiring management such as adjusting the dialysis solution if hypercalcemia is suspected. Bone-related complications like osteoporosis, osteomalacia, and fibrous osteitis may occur, necessitating treatment with vitamin D3 preparations. It is crucial to maintain serum phosphorus levels within the normal range to prevent ectopic calcification. If headaches, nausea, vomiting, convulsions, or altered consciousness occur during dialysis, measures such as reducing the dialysis speed may be necessary. This drug is used for dialysis in patients with chronic renal failure and may be selectively used when acetic acid dialysis is challenging to manage. As it is a dialysis solution that does not contain glucose, it may be beneficial when blood sugar control is difficult in patients with glucose metabolism disorders. Regular blood tests to monitor electrolytes, acid-base balance, kidney function, and blood sugar are important. Safety during pregnancy has not been established, so women of childbearing potential should use this drug cautiously under medical supervision. The safety in pediatric patients has also not been sufficiently confirmed, requiring caution. Elderly patients should understand the characteristics of this drug well, and regular examination and treatment may be required to prevent bone complications with prolonged use. The water used for dialysis should be safe water subjected to strict purification processes, and precautions regarding potential membrane damage and bleeding risk must be observed. When preparing dialysis solutions, sodium bicarbonate solutions and other electrolyte solutions should not be mixed directly, but rather diluted accurately at defined concentrations. If the concentration is too high or low, side effects such as headaches, palpitations, blood pressure abnormalities, or altered consciousness may occur, thus caution is necessary. The electrolyte concentration and pH of the dialysis solution must be checked before use, and it should be applied immediately after preparation. The temperature should be adjusted to body temperature during use, and it should not be used for injection or peritoneal dialysis. Only cartridges compatible with specific dialysis systems should be used, and caution should be exercised to avoid overpressure or negative pressure exposure.

Side effects

  • Hypoglycemia
  • hypercalcemia
  • osteoporosis
  • osteomalacia
  • fibrous osteitis
  • heterotopic calcification
  • headache
  • nausea
  • vomiting
  • convulsions
Show 13 more
  • altered consciousness
  • discomfort
  • fatigue
  • hypotension
  • shock symptoms
  • hypertension
  • headache
  • palpitations
  • altered consciousness
  • limb weakness
  • generalized fatigue
  • chest discomfort
  • rapid drop in blood pressure

Not everyone experiences these, and they can vary from person to person.

Storage

This drug may be sensitive to air or moisture, so it should be stored in a tightly sealed container. Additionally, it should be kept away from extremely hot or cold places, ideally stored at a temperature between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White crystalline powder in a white polyethylene bag

Package unit

16.8 kilograms/box [(8.4 kilograms/PE bag x 2)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.